SELICK HAROLD E 4
4 · Protagonist Therapeutics, Inc · Filed Apr 11, 2023
Insider Transaction Report
Form 4
SELICK HAROLD E
Director
Transactions
- Exercise/Conversion
Common Stock
2023-04-10$0.87/sh+6,196$5,391→ 21,506 total - Exercise/Conversion
Stock Option (right to buy)
2023-04-10−6,196→ 0 totalExercise: $0.87Exp: 2023-09-26→ Common Stock (6,196 underlying)
Footnotes (2)
- [F1]The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date.
- [F2]The stock option is vested in full.